From: MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Reactivity patterns
GBM
Parenchymal
22/46
(48%)
Perivascular
2/46
(4%)
Parenchymal and perivascular
18/46
(39%)
Total reactive
42/46
(91%)